Prot#:MV-0109DP001: A Randomized, Multicenter, Double-Blind, Phase II Trial of KLH Conjugated Trivalent Ganglioside Vaccine Containing GM2, GD2 Lactone, and GD3 Lactone with the Immunological Adjuvant OPT-821 versus OPT-821 Alone in Metastatic Sarcoma Pat

  • Agulnik, Mark (PD/PI)

Project: Research project

Project Details

StatusFinished
Effective start/end date5/13/10 → 5/31/17

Funding

  • Jubilant Clinsys, Inc. (MV-0109DP001 // MV-0109DP001)
  • MabVax Therapeutics, Inc. (MV-0109DP001 // MV-0109DP001)